Jason Huo, PhD

Intra-Cellular Therapies, Inc., New York, New York

JCP
Efficacy of Lumateperone in Bipolar Depression With Mixed Features
Original Research

April 24, 2023

Lumateperone significantly improved depression symptoms, disease severity, and quality of life in patients with bipolar depression with mixed features.
Roger S. McIntyre, Suresh Durgam, Jason Huo, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe